Your browser doesn't support javascript.
loading
Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.
Silberman, Jason N; Bercow, Alexandra S; Gockley, Allison A; Eisenhauer, Eric L; Sisodia, Rachel; Randall, Thomas; Del Carmen, Marcela G; Goodman, Annekathryn; Castro, Cesar M; Melamed, Alexander; Bregar, Amy J.
Afiliación
  • Silberman JN; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: jsilberman1@bwh.harvard.edu.
  • Bercow AS; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Gockley AA; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Eisenhauer EL; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Sisodia R; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Randall T; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Del Carmen MG; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Goodman A; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Castro CM; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Melamed A; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States; Division of Gynecologic Oncology, Wentworth-Douglass H
  • Bregar AJ; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States; Division of Gynecologic Oncology, Wentworth-Douglass H
Gynecol Oncol ; 175: 60-65, 2023 08.
Article en En | MEDLINE | ID: mdl-37327540
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudio: Prognostic_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudio: Prognostic_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos